Stay updated on Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page.

Latest updates to the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA new Revision: v3.6.5 was added and the previous Revision: v3.6.4 was removed, indicating a minor update to the page's version metadata.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page revision label was updated from Revision: v3.6.3 to Revision: v3.6.4, indicating a small frontend update to the study details page. This change does not modify study content or data.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page shows a new revision tag: v3.6.3, replacing the previous v3.6.1. This indicates a newer version of the page content.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision: v3.6.1 is now displayed, replacing the previous v3.6.0. This reflects a frontend version update and does not modify study details or content on the page.SummaryDifference0.0%

- Check74 days agoChange DetectedThe study page now shows 'No longer looking for participants', signaling that recruitment is closed for this study. Additional navigational or labeling updates were applied, including new sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', and a minor heading formatting change from 'Intervention / Treatment' to 'Intervention/Treatment'.SummaryDifference0.2%

- Check82 days agoChange DetectedThe page footer now displays Revision: v3.5.5, replacing Revision: v3.5.4. This indicates a minor update to the page's revision history without changing its content.SummaryDifference0.0%

Stay in the know with updates to Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page.